Viatris (NASDAQ: VTRS)
Viatris Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Viatris Company Info
Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses operations with developing markets and emerging economies including countries in Asia, the Middle East, South and Central America, Africa and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.
News & Analysis
Is Viatris a Great Dividend Stock or Just a Value Trap?
Investors can collect a high yield with Viatris, but is it a risky payout to rely on?
Viatris Just Sold Off 3 Key Segments. Is It Still a Buy?
There's a chance shareholders won't notice any difference.
Could Viatris Stock Help You Become a Millionaire?
Viatris' broad portfolio gives the business lots of stability and plenty of opportunities -- but is there enough there for the stock to be a great long-term investment?
Want to Collect $500 in Dividends Every Month? Invest $90,000 in These 3 Stocks
These stocks offer some mouth-watering payouts.
3 Pharmaceutical Stocks That Are Too Cheap to Ignore
Viatris, GSK, and Organon are all trading at less than 7 times earnings.
CVS Health Just Created a New Problem For Viatris. Here's What You Need to Know
CVS just fired a shot across Viatris' bow.
Viatris Stock: Bear vs. Bull
This is a case where both sides have compelling arguments.
Where Will Viatris Be in 5 Years?
Can this become a good growth business to invest in?
Valuation
Earnings Transcripts
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.